Showing results (181-190 of 545) with videos related to
Sort By:
Pageof 55
Progress in Cardiovascular Diseases|March 11, 2014
Current trends in reducing cardiovascular risk factors in the United States: focus on worksite health and wellnessLawrence P Cahalin, Jonathan Myers, Leonard Kaminsky, et al.Journal of the American Heart Association|September 21, 2020
Effects of Home-Based Cardiac Rehabilitation on Time to Enrollment and Functional Status in Patients With Ischemic Heart DiseaseDavid W Schopfer, Mary A Whooley, Kelly Allsup, et al.Journal of Agricultural and Food Chemistry|September 19, 2012
Ceramides as possible nutraceutical compounds: characterization of the ceramides of the Moro blood orange ( Citrus sinensis )Manuela Valsecchi, Laura Mauri, Riccardo Casellato, et al.The New England Journal of Medicine|February 14, 2007
Stent thrombosis in randomized clinical trials of drug-eluting stentsLaura Mauri, Wen-hua Hsieh, Joseph M Massaro, et al.American Heart Journal|June 23, 2014
Delay in reperfusion with transradial percutaneous coronary intervention for ST-elevation myocardial infarction: Might some delays be acceptable?Neil J Wimmer, David J Cohen, Jason H Wasfy, et al.JACC. Cardiovascular Interventions|October 25, 2011
Dual antiplatelet therapy duration and clinical outcomes following treatment with zotarolimus-eluting stentsDavid E Kandzari, Colin S Barker, Martin B Leon, et al.Glycoconjugate Journal|February 23, 2021
Turning the spotlight on the oligosaccharide chain of GM1 gangliosideElena Chiricozzi, Erika Di Biase, Giulia Lunghi, et al.JACC. Cardiovascular Interventions|March 25, 2017
Long-Term Outcomes of Stenting the Proximal Left Anterior Descending Artery in the PROTECT TrialAriel Roguin, Edoardo Camenzind, Arthur Kerner, et al.American Heart Journal|September 29, 2009
Relationship of age and exercise performance in patients with heart failure: the HF-ACTION studyDaniel E Forman, Robert Clare, Dalane W Kitzman, et al.The American Journal of Cardiology|August 9, 2006
Relation of brain natriuretic peptide levels to cognitive dysfunction in adults > 55 years of age with cardiovascular diseaseJohn Gunstad, Athena Poppas, Steven Smeal, et al.Pageof 55